MiMedx Group
IPOHome | MIMEDX
Public · MARIETTA, United States · Founded 2008 · $150.0M raised
- Headquarters
- MARIETTA, Georgia
- Employees
- 501–1000
- Founded
- 2008
- Business Model
- B2B
- Website
- mimedx.com
- Total Funding
- $150.0M
- Last Round
- $150.0M Private EquityJul 2020
- Rounds
- 1
- Type
- Public
About
MiMedx is a pioneer and leader in placental biologics dedicated to delivering innovative healing solutions to patients and healthcare professionals. With over a decade of experience, the company develops and distributes placental tissue allografts — including EPIFIX, AMNIOFIX, and related products — for use in advanced wound care, burn treatment, and surgical recovery applications. MiMedx's vision is to be the leading global provider of healing solutions through relentless innovation.
Summary
MiMedx Group is a Biotech company based in MARIETTA, United States, founded in 2008. It has raised $150.0M in total across 1 round, most recently a $150.0M Private Equity round in Jul 2020. Investors include EW Healthcare Partners.
Tech & App Stack
7 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company